Development of Multiple Cloning Site cis-Vectors for Recombinant Adeno-Associated Virus Production

Recombinant adeno-associated virus (rAAV) has become a very popular gene therapy vector in the past several years. A cis-plasmid is used to generate the rAAV stocks. In this plasmid, the entire expression cassette is incorporated between two AAV inverted terminal repeats. The construction of cis-pla...

Full description

Saved in:
Bibliographic Details
Main Authors: Yongping Yue, Dongsheng Duan
Format: Article
Language:English
Published: Taylor & Francis Group 2002-09-01
Series:BioTechniques
Online Access:https://www.future-science.com/doi/10.2144/02333dd03
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850152559204892672
author Yongping Yue
Dongsheng Duan
author_facet Yongping Yue
Dongsheng Duan
author_sort Yongping Yue
collection DOAJ
description Recombinant adeno-associated virus (rAAV) has become a very popular gene therapy vector in the past several years. A cis-plasmid is used to generate the rAAV stocks. In this plasmid, the entire expression cassette is incorporated between two AAV inverted terminal repeats. The construction of cis-plasmid has been problematic because of the high-frequency recombination of the viral inverted terminal repeats. Here we describe the design and construction of several multiple cloning site cis-plasmids that are driven by five different promoters, including the ubiquitous cytomegalovirus enhancer/chicken β-actin (CAG), cytomegalovirus (CMV), rous sarcoma virus (RSV), simian virus 40 (SV40), and a muscle-specific promoter (CK6). The application of these multiple cloning site cis-plasmids improves the cloning efficiency. As an example of the utilization of these multiple cloning site vectors, the prokaryotic β-galactosidase cDNA was cloned in the multiple cloning site cis-plasmids. High-level rAAV-mediated β-galactosidase expression was achieved in HeLa cells from CAG, CMV, RSV, and SV40 promoters, respectively, but not from the CK6 promoter. In vivo application in the adult mdx mouse (mouse model for Duchenne muscular dystrophy) muscle revealed efficient transgene expression from CMV and CK6 promoters, followed by CAG and RSV promoters. The SV40 promoter was the least efficient.
format Article
id doaj-art-c9cf8de822ad4891b688853a73e95b92
institution OA Journals
issn 0736-6205
1940-9818
language English
publishDate 2002-09-01
publisher Taylor & Francis Group
record_format Article
series BioTechniques
spelling doaj-art-c9cf8de822ad4891b688853a73e95b922025-08-20T02:25:57ZengTaylor & Francis GroupBioTechniques0736-62051940-98182002-09-0133367267810.2144/02333dd03Development of Multiple Cloning Site cis-Vectors for Recombinant Adeno-Associated Virus ProductionYongping Yue0Dongsheng Duan11The University of Missouri, Columbia, MO, USA1The University of Missouri, Columbia, MO, USARecombinant adeno-associated virus (rAAV) has become a very popular gene therapy vector in the past several years. A cis-plasmid is used to generate the rAAV stocks. In this plasmid, the entire expression cassette is incorporated between two AAV inverted terminal repeats. The construction of cis-plasmid has been problematic because of the high-frequency recombination of the viral inverted terminal repeats. Here we describe the design and construction of several multiple cloning site cis-plasmids that are driven by five different promoters, including the ubiquitous cytomegalovirus enhancer/chicken β-actin (CAG), cytomegalovirus (CMV), rous sarcoma virus (RSV), simian virus 40 (SV40), and a muscle-specific promoter (CK6). The application of these multiple cloning site cis-plasmids improves the cloning efficiency. As an example of the utilization of these multiple cloning site vectors, the prokaryotic β-galactosidase cDNA was cloned in the multiple cloning site cis-plasmids. High-level rAAV-mediated β-galactosidase expression was achieved in HeLa cells from CAG, CMV, RSV, and SV40 promoters, respectively, but not from the CK6 promoter. In vivo application in the adult mdx mouse (mouse model for Duchenne muscular dystrophy) muscle revealed efficient transgene expression from CMV and CK6 promoters, followed by CAG and RSV promoters. The SV40 promoter was the least efficient.https://www.future-science.com/doi/10.2144/02333dd03
spellingShingle Yongping Yue
Dongsheng Duan
Development of Multiple Cloning Site cis-Vectors for Recombinant Adeno-Associated Virus Production
BioTechniques
title Development of Multiple Cloning Site cis-Vectors for Recombinant Adeno-Associated Virus Production
title_full Development of Multiple Cloning Site cis-Vectors for Recombinant Adeno-Associated Virus Production
title_fullStr Development of Multiple Cloning Site cis-Vectors for Recombinant Adeno-Associated Virus Production
title_full_unstemmed Development of Multiple Cloning Site cis-Vectors for Recombinant Adeno-Associated Virus Production
title_short Development of Multiple Cloning Site cis-Vectors for Recombinant Adeno-Associated Virus Production
title_sort development of multiple cloning site cis vectors for recombinant adeno associated virus production
url https://www.future-science.com/doi/10.2144/02333dd03
work_keys_str_mv AT yongpingyue developmentofmultiplecloningsitecisvectorsforrecombinantadenoassociatedvirusproduction
AT dongshengduan developmentofmultiplecloningsitecisvectorsforrecombinantadenoassociatedvirusproduction